108 related articles for article (PubMed ID: 7858957)
1. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol.
Mihara K; Oka Y; Sawai K; Takakura Y; Hashida M
J Drug Target; 1994; 2(4):317-21. PubMed ID: 7858957
[TBL] [Abstract][Full Text] [Related]
2. Study of the effect of superoxide dismutase on acute renal failure in dogs.
Kónya L; Szénási G; Bencsáth P; Fehér J
Acta Med Hung; 1991; 48(1-2):79-85. PubMed ID: 1813861
[TBL] [Abstract][Full Text] [Related]
3. Ischemic acute renal failure in the rat: effects of L-arginine and superoxide dismutase on renal function.
Schramm L; Seibold A; Schneider R; Zimmermann J; Netzer KO; Wanner C
J Nephrol; 2008; 21(2):229-35. PubMed ID: 18446718
[TBL] [Abstract][Full Text] [Related]
4. Role of peroxynitrite and recombinant human manganese superoxide dismutase in reducing ischemia-reperfusion renal tissue injury.
Rahman NA; Mori K; Mizukami M; Suzuki T; Takahashi N; Ohyama C
Transplant Proc; 2009 Nov; 41(9):3603-10. PubMed ID: 19917352
[TBL] [Abstract][Full Text] [Related]
5. [Status of treatment with free radical scavengers following kidney and pancreas transplantation].
Abendroth D; Schneeberger H; Schleibner S; Illner WD; Land W
Zentralbl Chir; 1992; 117(9):502-8. PubMed ID: 1441789
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats.
Gandhi C; Zalawadia R; Balaraman R
Ren Fail; 2008; 30(9):921-30. PubMed ID: 18925533
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
[TBL] [Abstract][Full Text] [Related]
8. Poly(vinylpyrrolidone-co-dimethyl maleic acid) as a novel renal targeting carrier.
Yamamoto Y; Tsutsumi Y; Yoshioka Y; Kamada H; Sato-Kamada K; Okamoto T; Mukai Y; Shibata H; Nakagawa S; Mayumi T
J Control Release; 2004 Mar; 95(2):229-37. PubMed ID: 14980771
[TBL] [Abstract][Full Text] [Related]
9. [Effect of intravenous recombinant human superoxide dismutase on reducing reperfusion injury].
Neya K
Nihon Kyobu Geka Gakkai Zasshi; 1993 Feb; 41(2):211-20. PubMed ID: 8473785
[TBL] [Abstract][Full Text] [Related]
10. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
Teraishi K; Kurata H; Nakajima A; Takaoka M; Matsumura Y
Eur J Pharmacol; 2004 Nov; 505(1-3):205-11. PubMed ID: 15556154
[TBL] [Abstract][Full Text] [Related]
11. Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats.
Francis JW; Ren J; Warren L; Brown RH; Finklestein SP
Exp Neurol; 1997 Aug; 146(2):435-43. PubMed ID: 9270054
[TBL] [Abstract][Full Text] [Related]
12. Improved anti-oxidant activity of superoxide dismutase by direct chemical modification.
Ishimoto N; Nemoto T; Nagayoshi K; Yamashita F; Hashida M
J Control Release; 2006 Mar; 111(1-2):204-11. PubMed ID: 16466666
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification.
Mihara K; Sawai K; Takakura Y; Hashida M
Biol Pharm Bull; 1994 Feb; 17(2):296-301. PubMed ID: 7515745
[TBL] [Abstract][Full Text] [Related]
14. Mannosylated superoxide dismutase inhibits hepatic reperfusion injury in rats.
Kondo S; Segawa T; Tanaka K; Izawa K; Hashida M; Kanematsu T
J Surg Res; 1996 Jan; 60(1):36-40. PubMed ID: 8592429
[TBL] [Abstract][Full Text] [Related]
15. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat.
Vukicevic S; Basic V; Rogic D; Basic N; Shih MS; Shepard A; Jin D; Dattatreyamurty B; Jones W; Dorai H; Ryan S; Griffiths D; Maliakal J; Jelic M; Pastorcic M; Stavljenic A; Sampath TK
J Clin Invest; 1998 Jul; 102(1):202-14. PubMed ID: 9649574
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of ligustrazine on ischemia-reperfusion injury in rat kidneys.
Sun L; Li Y; Shi J; Wang X; Wang X
Microsurgery; 2002; 22(8):343-6. PubMed ID: 12497570
[TBL] [Abstract][Full Text] [Related]
17. Prevention of ischemia-reperfusion damage with polymerized superoxide dismutase.
Rocca M; Capelli S; Fini M; Maltarello MC; Veronese FM; Caliceti P; Giardino R
Boll Soc Ital Biol Sper; 1995; 71(5-6):125-32. PubMed ID: 8519486
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation.
Mizoe A; Kondo S; Azuma T; Fujioka H; Tanaka K; Hashida M; Kanematsu T
J Surg Res; 1997 Dec; 73(2):160-5. PubMed ID: 9441811
[TBL] [Abstract][Full Text] [Related]
19. Selective antagonism of the postsynaptic alpha(1)-adrenoceptor is protective against ischemic acute renal failure in rats.
Fujii T; Sugiura T; Ohkita M; Kobuchi S; Takaoka M; Matsumura Y
Eur J Pharmacol; 2007 Nov; 574(2-3):185-91. PubMed ID: 17651724
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological advantages of conjugation of Cu, Zn-superoxide dismutase with succinylated keratin fragment: improvement of biological properties and resistance to oxidative damage.
Noda J; Otagiri M; Akaike T; Maeda H
J Pharmacol Exp Ther; 1996 Oct; 279(1):162-71. PubMed ID: 8858989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
